New Key Statistics Module, Z-Score and F-Score
NAS:TRDA Key Ratios
| Market Cap $ M | 675.43 |
| Enterprise Value $ M | 297.13 |
| P/E(ttm) | 11.35 |
| PE Ratio without NRI | 11.35 |
| Forward PE Ratio | 39.96 |
| Price/Book | 1.60 |
| Price/Sales | 2.97 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 215.00 |
| EPS (TTM) $ | 1.59 |
| Beneish M-Score | -1.25 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 5.14 |
| EV-to-EBITDA | 4.85 |
| PEG | -- |
| Shares Outstanding M | 37.42 |
| Net Margin (%) | 25.53 |
| Operating Margin % | 26.85 |
| Pre-tax Margin (%) | 35.51 |
| Quick Ratio | 6.59 |
| Current Ratio | 6.59 |
| ROA % (ttm) | 10.56 |
| ROE % (ttm) | 17.06 |
| ROIC % (ttm) | 19.16 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.48 |
TRDA Number of Guru Trades
TRDA Volume of Guru Trades
Gurus Latest Trades with NAS:TRDA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TRDA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Entrada Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TRDA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers